Aggrenox To Treat Acute Covid-19
Condition: Covid19 Interventions: Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally; Other: Standard of care Sponsors: Rutgers, The State University of New Jersey; Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2020 Category: Research Source Type: clinical trials
Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
Condition: HealthyInterventions: Drug: Aggrenox; Drug: Dipyridamole; Drug: Aspirin; Drug: LansoprazoleSponsor: Boehringer IngelheimCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2014 Category: Research Source Type: clinical trials
Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus ErythematosusInterventions: Drug: extended release dipyridamole 200mg/aspirin 25mg; Drug: 81mg aspirinSponsors: Oklahoma Medical Research Foundation; Oklahoma Rheumatic Disease Research Cores CenterActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2013 Category: Research Source Type: clinical trials
